植物新藥研發-植物新藥

EZH1 mainly solves related problems generated by dermatitis, including atopic dermatitis, seborrheic dermatitis, psoriasis, etc. Currently, the immune system-related diseases in the world such as atopic dermatitis can only rely on steroids, immunosuppressants or A acid derivatives (U.S. FDA announced that exposing to sunlight increases carcinogenic risk after using) for treatment, and allergies will not be cured. Inflamed wounds develop scars and pigmentation of wounds will not fade. Initially, steroid withdrawal phenomenon appears when patients use EZH1 right after long-term use of steroids: the skin will be more redness, itching, scaling, cracking, and will deepen the original inflammation. Keep using for three to four weeks, the allergy reaction will be reduced, affected skin wound will be healed, newborn healthy cells will be generated, and no pigmentation as well as reduction of the recurrence frequency. No dependence will be developed after long-term use of EZH1. No steroid-like rebound reaction and no immunosuppressants are contained as well as no risk of cancer. Symptoms of atopic dermatitis will be reduced and the immune system will gradually return to normal. EZH1 is the botanical new drug that dermatitis patients eagerly awaited.
EH-EZH1-01
EH-EZH1-02        
EH-EZH1-03